Perk Labs Inc.
PKLBF · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 9.1% | -54.7% | 99.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 29.5% | 5.2% | -6.2% | -15% |
| R&D Expenses | $1 | $1 | $1 | $3 |
| G&A Expenses | $1 | $2 | $2 | $3 |
| SG&A Expenses | $2 | $2 | $2 | $4 |
| Sales & Mktg Exp. | $0 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $3 | $3 | $7 |
| Operating Income | -$3 | -$3 | -$3 | -$7 |
| % Margin | -8,123.6% | -11,075.3% | -5,052.3% | -23,089.1% |
| Other Income/Exp. Net | -$1 | $1 | -$1 | -$1 |
| Pre-Tax Income | -$3 | -$1 | -$4 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$1 | -$4 | -$8 |
| % Margin | -10,694.3% | -5,137% | -7,028.5% | -25,173.7% |
| EPS | -0.017 | -0.009 | -0.032 | -0.059 |
| % Growth | -102.3% | 72.9% | 46.4% | – |
| EPS Diluted | -0.017 | -0.009 | -0.032 | -0.059 |
| Weighted Avg Shares Out | 194 | 174 | 142 | 137 |
| Weighted Avg Shares Out Dil | 194 | 174 | 142 | 137 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$1 | -$4 | -$8 |
| % Margin | -10,152.9% | -4,618.8% | -6,857.9% | -23,837% |